These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22588231)

  • 1. Screening, diagnosis, and treatment of dyslipidemia among persons with persistent mental illness: a literature review.
    Vanderlip ER; Fiedorowicz JG; Haynes WG
    Psychiatr Serv; 2012 Jul; 63(7):693-701. PubMed ID: 22588231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of expert consensus to improve atherogenic dyslipidemia management.
    Millán Núñez-Cortés J; Pedro-Botet J; Brea-Hernando Á; Díaz-Rodríguez Á; González-Santos P; Hernández-Mijares A; Mantilla-Morató T; Pintó-Sala X; Simó R
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):36-44. PubMed ID: 24774262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ
    Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus on management of dyslipidemia in pediatrics].
    Comité de Nutrición
    Arch Argent Pediatr; 2015 Apr; 113(2):177-86. PubMed ID: 25727831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of dyslipidemia in moderate to severe meibomian gland dysfunction.
    Dao AH; Spindle JD; Harp BA; Jacob A; Chuang AZ; Yee RW
    Am J Ophthalmol; 2010 Sep; 150(3):371-375.e1. PubMed ID: 20619393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal versus targeted blood cholesterol screening among youth: The CARDIAC project.
    Ritchie SK; Murphy EC; Ice C; Cottrell LA; Minor V; Elliott E; Neal W
    Pediatrics; 2010 Aug; 126(2):260-5. PubMed ID: 20624798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-HDL-cholesterol in an adolescent diabetes population.
    Kuryan RE; Jacobson MS; Frank GR
    J Clin Lipidol; 2014; 8(2):194-8. PubMed ID: 24636179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated care: nonfasting screening for cardiovascular risk among individuals taking second-generation antipsychotics.
    Vanderlip ER; Chwastiak LA; McCarron RM
    Psychiatr Serv; 2014 May; 65(5):573-6. PubMed ID: 24788735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.